Chris has over 16 years of scientific experience focused on target identification, validation and drug discovery in multiple areas of biology including oncology, metabolic disorders and cardiovascular disease. Bench leader with extensive in vitro technical skills centered around target identification, validation and mechanism of action studies to drive drug discovery efforts. Chris brings deep expertise in cellular and molecular biology, focused on finding novel solutions to challenging problems, uncovering new biological insights and unlocking new therapeutic opportunities.